High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
about
Cilostazol inhibits accumulation of triglyceride in aorta and platelet aggregation in cholesterol-fed rabbitsEvaluation of genetic risk scores for lipid levels using genome-wide markers in the Framingham Heart Study.Long-term plasma lipid changes associated with a first birth: the Coronary Artery Risk Development in Young Adults studyLactation and changes in maternal metabolic risk factors.Prevalence of persistent lipid abnormalities in statin-treated patients: Belgian results of the Dyslipidaemia International Study (DYSIS).Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation.Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic controlCircadian aspects of postprandial metabolism.Alcohol, nutrition and health maintenance: selected aspects.Treatment of hypertriglyceridemia with omega-3 fatty acids: a systematic review.Pregnancy during adolescence has lasting adverse effects on blood lipids: a 10-year longitudinal study of black and white females.Fibrates in combination with statins in the management of dyslipidemia.Generating genetic risk scores from intermediate phenotypes for use in association studies of clinically significant endpoints.Dietary quality among Tehranian adults in relation to lipid profile: findings from the Tehran Lipid and Glucose Study.Therapeutic angiogenesis for coronary artery disease: clinical trials of proteins, plasmids, adenovirus and stem cells.Can breast cancer patients use soyafoods to help reduce risk of CHD?Review of Garcinia mangostana and its Xanthones in Metabolic Syndrome and Related Complications.Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.Effect of pomegranate seed oil on hyperlipidaemic subjects: a double-blind placebo-controlled clinical trial.Novel rare alleles of ABCA1 are exclusively associated with extreme high-density lipoprotein-cholesterol levels among the Han Chinese.Total lipid management and cardiovascular disease in the dyslipidemia international study.Effects of aspirin when added to the prostaglandin D2 receptor antagonist laropiprant on niacin-induced flushing symptoms.Association between plasma phospholipid saturated fatty acids and metabolic markers of lipid, hepatic, inflammation and glycaemic pathways in eight European countries: a cross-sectional analysis in the EPIC-InterAct study.Association of apolipoprotein E gene polymorphisms with blood lipids and their interaction with dietary factors.
P2860
Q28728089-B5A901BC-D557-4BF8-B128-53CC3EDA6038Q33519320-B022DC2D-9440-4DD6-9308-7592EB67C2FBQ33938110-5513F69C-ECB5-4037-92EB-2CA7B7246C52Q34095361-8C2BCB08-B209-4BF6-8C2B-088DC26228D2Q34693274-6C896D37-6D59-4FF5-9F4B-EE2E166B7351Q35071237-0F4944B9-B827-4B77-BF06-00FD7AA101EFQ35142685-FFC38A74-E25B-408A-85D7-5A2BB167640DQ35554777-A7D19231-0715-4BBD-849D-8DE8621EC4C8Q35740502-8428AF16-A772-49D6-B68E-32B8475F2596Q35923734-99A0F579-8D9A-4012-BAD8-472E89247A41Q36037536-1D871EE8-0AF6-458D-9F9E-FFBA56C3A66EQ36366283-D286DE65-6C58-466A-8978-4E34E01519FDQ36540012-9DF94565-36DF-4791-97EA-70681A581F6EQ36985337-1B8FAFE7-AC73-4742-85D3-D6411B7E1718Q37608469-1D1086F6-1CB6-4A18-8623-F789F3EA63F3Q38032972-0C72B5EF-7B6C-473C-B394-972BC115FFCDQ39401828-BD5BE077-1951-4A7F-AF0D-6B516387FD2DQ39765898-0E31F410-C71A-4E48-8512-81FFDCF8926FQ43119861-99FD4DDB-E4EC-4B15-A630-C265B1DFC7B5Q43278591-FE2C9D02-65AC-47F1-9496-43A10146A9D2Q43569682-03D5D07D-C4E4-498F-83E3-F8F936519AA3Q46107346-93612E61-CEF7-4F3E-8935-DA996238F26FQ47336123-BD4A233D-5603-4DE0-A98B-B9B9FAA29946Q53070205-F08EBDC7-33A6-49FE-AB50-E969AB9649CC
P2860
High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
High-density lipoprotein chole ...... ating coronary artery disease.
@ast
High-density lipoprotein chole ...... ating coronary artery disease.
@en
type
label
High-density lipoprotein chole ...... ating coronary artery disease.
@ast
High-density lipoprotein chole ...... ating coronary artery disease.
@en
prefLabel
High-density lipoprotein chole ...... ating coronary artery disease.
@ast
High-density lipoprotein chole ...... ating coronary artery disease.
@en
P356
P1476
High-density lipoprotein chole ...... ating coronary artery disease.
@en
P2093
Antonio M Gotto
P304
P356
10.1067/MHJ.2002.130301
P407
P433
P577
2002-12-01T00:00:00Z